Steven Cohen’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11M Buy
1,501,268
+479,075
+47% +$4.52M 0.01% 1299
2026
Q2
$11.1M Buy
+1,022,193
New +$11.7M 0.01% 1220
2024
Q4
– Sell
-439,816
Closed -$7.95M – 2364
2024
Q3
$7.95M Buy
+439,816
New +$6.15M 0.02% 729
2023
Q2
– Sell
-11,505
Closed -$82.1K – 2644
2023
Q1
$82.1K Buy
+11,505
New +$101K ﹤0.01% 1674

Other funds holding PHAT

Steven Cohen's PHAT Position: Q3 2026 in Review

Steven Cohen increased its Phathom Pharmaceuticals (PHAT) stake by 47% in Q3 2026, buying an estimated $4.52M and bringing the position to 1,501,268 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #1299.

Steven Cohen first reported a position in PHAT in Q1 2023 and has held it in 4 quarters since. The position peaked at $11.1M in Q2 2026. 159 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.

  • Steven Cohen held 1,501,268 shares of Phathom Pharmaceuticals worth $11M as of Q3 2026.
  • Steven Cohen bought 479,075 Phathom Pharmaceuticals shares in Q3 2026, an estimated $4.52M.
  • Phathom Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1299 holding.
  • Steven Cohen first reported a position in Phathom Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
  • Steven Cohen's Phathom Pharmaceuticals position peaked at $11.1M in Q2 2026.
  • 159 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.